Disclosed are compounds and pharmaceutically acceptable salts and stereoisomers thereof that are suitable for cellular labeling or the treatment of cancer. Also disclosed are pharmaceutical compositions containing same, and methods of making and using the compounds.

Disclosed herein is an efficient, economical, industrially advantageous, straight-through process for the preparation of cyclic amides, also referred as lactams, in substantially pure form and high yield, from the corresponding cyclic ketones and a hydroxylammonium salt, using a combination of amphoteric metal oxide or amphoteric masked metal oxide and a base.

Disclosed herein is an efficient, economical, industrially advantageous, straight-through process for the preparation of cyclic amides, also referred as lactams, in substantially pure form and high yield, from the corresponding cyclic ketones and a hydroxylammonium salt, using a combination of amphoteric metal oxide or amphoteric masked metal oxide and a base.

A monopropellant includes 30-70% by weight of an oxidizer including hydroxylammonium nitrate, 5-50% by weight of a fuel, and a burn rate modifier in a non-zero amount of up to 3% by weight. The burn rate modifier can be selected from vanadium salts, iron salts, and combinations thereof. The monopropellant is a stable liquid between 20 C and 100 C at ambient pressure.

Disclosed herein is an efficient, economical, industrially advantageous, straight-through process for the preparation of cyclic amides, also referred as lactams, in substantially pure form and high yield, from the corresponding cyclic ketones and a hydroxylammonium salt, using a combination of amphoteric metal oxide or amphoteric masked metal oxide and a base.

Disclosed herein is an efficient, economical, industrially advantageous, straight-through process for the preparation of cyclic amides, also referred as lactams, in substantially pure form and high yield, from the corresponding cyclic ketones and a hydroxylammonium salt, using a combination of amphoteric metal oxide or amphoteric masked metal oxide and a base.

Methods for the photoreduction of molecules are provided. The methods use diamond having a negative electron affinity as a photocatalyst, taking advantage of its ability to act as a solid-state electron emitter that is capable of inducing reductions without the need for reactants to adsorb onto its surface. The methods comprise illuminating a fluid sample comprising the molecules to be reduced and hydrogen surface-terminated diamond having a negative electron affinity with light comprising a wavelength that induces the emission of electrons from the diamond directly into the fluid sample. The emitted electrons induce the reduction of the molecules to form a reduction product.

A monopropellant includes 30-70% by weight of an oxidizer including hydroxylammonium nitrate, 5-50% by weight of a fuel, and a burn rate modifier in a non-zero amount of up to 3% by weight. The burn rate modifier can be selected from vanadium salts, iron salts, and combinations thereof. The monopropellant is a stable liquid between 20 C and 100 C at ambient pressure.